Norwalk Leslie V (CIK 1533568) reported 15 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-26). Recent activity: Buy ARVN (15,527 shares), Sell NBIX (1,250 shares), Buy NBIX (1,659 shares), Buy CVS (1,447 shares), Sell NBIX (3,810 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | ARVINAS, INC. (ARVN) | Director | Buy | 15,527 | $0 |
| 2026-06-08 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 1,250 | $210,072 |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,659 | $0 |
| 2026-05-15 | CVS HEALTH Corp (CVS) | Director | Buy | 1,447 | $140,576 |
| 2026-05-14 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 3,810 | $590,601 |
| 2026-01-12 | GLOBUS MEDICAL INC (GMED) | Director | Sell | 2,000 | $202,200 |
| 2025-12-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 8,276 | $764,289 |
| 2025-12-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,724 | $146,454 |
| 2025-12-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 5,000 | $761,150 |
| 2025-12-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 1,190 | $184,557 |
| 2025-12-16 | GLOBUS MEDICAL INC (GMED) | Director | Sell | 4,000 | $355,400 |
| 2025-11-21 | CVS HEALTH Corp (CVS) | Director | Buy | 1,652 | $125,618 |
| 2025-06-27 | ARVINAS, INC. (ARVN) | Director | Buy | 16,025 | $0 |
| 2025-05-22 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,435 | $0 |
| 2025-05-19 | CVS HEALTH Corp (CVS) | Director | Buy | 2,077 | $125,596 |
Source: SEC Form 4 filings · as of 2026-06-26